Navigation Links
Idenix Pharmaceuticals to Present at the Seventh Annual Needham and Company, LLC Biotechnology and Medical Technology Conference
Date:6/4/2008

CAMBRIDGE, Mass, June 4 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management will present a corporate overview at the Seventh Annual Needham and Company, LLC Biotechnology and Medical Technology Conference on Thursday, June 12, 2008 at 3:30 pm. ET at The New York Palace Hotel in New York, NY.

The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com. Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replays will be available on the Idenix website for two weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus and HIV. For further information about Idenix, please refer to http://www.idenix.com.

Idenix Pharmaceuticals Contact:

Ronald Renaud (617) 995-9881


'/>"/>
SOURCE Idenix Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Idenix Pharmaceuticals Restructures to Concentrate Efforts on HCV and HIV Programs
2. Idenix to Host Conference Call Discussing Third Quarter 2007 Financial Results
3. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
4. Idenix to Host Conference Call Discussing Fourth Quarter 2007 Financial Results
5. Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL)
6. Idenix Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
7. Idenix Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
8. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
9. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...wire-FirstCall/ - OncoGenex Pharmaceuticals, Inc (... Battle Against Cancer, panel at the RBC Capital M...ember 11 at 8:00 am ET at the Westin Times Square ...coGenex, President and Chief Executive Officer, Sc...company,s oncology drug pipeline and its approach ...
(Date:12/3/2008)...ent Executed to Support ConjuChem,s, R&D...nmark, Dec. 3 /PRNewswire-FirstCall/ - ConjuChem B...rma UK Ltd., a subsidiary of Novozymes A/S (LSE:NV... into a long-term Manufacturing and Supply Agreeme...upply its recombinant human albumin, Recombumin(R)...
(Date:12/3/2008)...va BioSciences, Inc., announced,today that it has... the,CATANIA(TM) Coronary Stent System with NanoT...had any stent thrombosis in clinical studies. It i... Europe and now some Middle,Eastern countries wit...ently,CeloNova notes that it has received regula...
(Date:12/3/2008)...Advanced Life Sciences Holdings,Inc. (Nasdaq: ...g,Administration (FDA) has accepted and filed the...ycin, a novel once-a-day oral antibiotic, for the ...pneumonia (CAP). The FDA has,established a goal ...pated,target action date of the cethromycin NDA w...
Breaking Biology Technology:ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4 2ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4 3CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 2CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East 3Advanced Life Sciences Announces Cethromycin NDA Accepted for Filing by FDA for the Treatment of Community Acquired Pneumonia 2Advanced Life Sciences Announces Cethromycin NDA Accepted for Filing by FDA for the Treatment of Community Acquired Pneumonia 3
...Amazing what can happen in three short months! Th...the end of the first quarter, but have picked up s...ing from a one percent decline to a very robust ei...ind was the NASADQ National Market , which showed... the half year. , ,Unfortunately, the main biotech...
... Madison, Wis . - Opponents of human embryonic ste...roduce any cures. That,s like asking a fourth-grad... only nine years since University of Wisconsin-Ma...keep stem cells alive long enough to study them. ,...uman embryonic stem-cell research helped bring on ...
... Madison, Wis . If Wisconsin continues to build on...esses eventually take care of themselves? , ,Wisco...y are impressive when compared with other states o...specially when it comes to training and retaining ...l shortages of skilled workers - from construction...
..., , , Researchers in New ...d a unique control,strategy to achieve high anti...tion process of,Streptomyces hygroscopicus. Usin...ith,touchscreen interface augmented by the power...ftware, scientists were successful in optimizing t...
Other Biology Technology:Midwest life science stocks kept sizzling in Q2 2Midwest life science stocks kept sizzling in Q2 3Midwest life science stocks kept sizzling in Q2 4Midwest life science stocks kept sizzling in Q2 5Midwest life science stocks kept sizzling in Q2 6Separating hope from hype in stem-cell research 2Separating hope from hype in stem-cell research 3To be a player in the "Knowledge Economy," Wisconsin needs more tech workers 2To be a player in the "Knowledge Economy," Wisconsin needs more tech workers 3To be a player in the "Knowledge Economy," Wisconsin needs more tech workers 4Rapamycin Optimized in 100 Liter Fermentor Using BioCommand Control Strategys 2Rapamycin Optimized in 100 Liter Fermentor Using BioCommand Control Strategys 3
(Date:12/4/2008)...ople who carry weight in the thighs and backside h...d pressure and heart disease than apple-shaped peo... from nutrition researchers at Washington Universi...ape comparisons don,t completely explain risk. , ...ars to be the real key to insulin resistance, chol...
(Date:12/4/2008)...roved tool to monitor deforestation and degradatio.... The Gordon and Betty Moore Foundation has awarde...Ecology with a $1.6-million grant to expand and im...em Lite), a new, user-friendly method that enables...l organizations (NGOs) to map tropical forests fro...
(Date:12/3/2008)...at the box office this week. The most exciting new... filmed by scientists using ground-breaking techno...ists at Sydney,s Centenary Institute have filmed a...followed the infection as it begins to spread thro... head of the Immune Imaging program at the Centena...
(Date:12/3/2008)... Institution of Oceanography at UC San Diego retur...ured unprecedented details of vibrant sea life and...ocumentations of new species and marine animals pr...ich included surveys at unexplored depths, have re... and evidence that human impacts have stretched do...
Breaking Biology News(10 mins):Apple or pear shape is not main culprit to heart woes -- it's liver fat 2Tropical forest carbon monitoring gets big boost 2Scientists film inner workings of the immune system 2Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 2Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 3Expeditions reveal gulf of California's deep sea secrets, as well as human imprints 4UCLA researchers locate and image prostate cancer as it spreads to lymph nodes 3999 1UCLA researchers locate and image prostate cancer as it spreads to lymph nodes 3999 2UCLA researchers locate and image prostate cancer as it spreads to lymph nodes 3999 3NuVal 28TM 29 Nutritional Scoring System Will Debut in Major U S Chains This September 23821 1NuVal 28TM 29 Nutritional Scoring System Will Debut in Major U S Chains This September 23821 2NuVal 28TM 29 Nutritional Scoring System Will Debut in Major U S Chains This September 23821 3Goldshield Wins SFO Case Interview With Chairman and CEO 23818 1Treating rare breast cancer with radiation therapy may lower recurrence rate 23815 1Treating rare breast cancer with radiation therapy may lower recurrence rate 23815 2
...East Coast fever destroys the small farmer,s dream...a million cattle and costing some $200 million ann...n countries in eastern and central Africa. Now, an...rst major step toward a vaccine to prevent East Co...3-17 early online edition of the Proceedings of t...
...f Michigan scientists have found a common genetic ...le much more likely to develop psoriasis ?a disfig...ORE-ESS-1), for psoriasis susceptibility 1, the ge...o be definitively identified in a large clinical s...ive treatments for psoriasis without the risks and...
...d even aggressive human behavior could explain why...ing a five-year downward trend in close encounters...rida research suggests. , Greater safety precautio...th sharks went a long way in reducing the total nu...fatalities from seven to four, said George Burgess...
...ave identified a handful of microRNAs (miRNAs) tha...ment of platelets ?blood cells critical to the bod...y also say some of these same miRNAs, when acting ...kemia. , "Basically, we found that a specific set ...evelopment, but turned on in certain platelet-rela...
Other Biology News:Genomics-based vaccine could prevent deadly cattle disease 2Genomics-based vaccine could prevent deadly cattle disease 3U-M scientists identify major psoriasis susceptibility gene 2U-M scientists identify major psoriasis susceptibility gene 3U-M scientists identify major psoriasis susceptibility gene 4World shark attacks dipped in 2005, part of long-term trend 2World shark attacks dipped in 2005, part of long-term trend 3MiRNA fingerprint identified in platelet formation 2
Kit for BASE20/50 dual control unit, includes mounting plate, HOLDER50T, HEATERPAD50, SRTDX temperature probe(s).
DTT; 1,4-Dithiothreitol from Roche Applied Science
...nd Tissue Staining Kits are intended for localizat...nd cytological specimens. These kits may be used w...R&D Systems or by other vendors. Briefly, detectio...omplex (ABC) with primary antibodies that reacted ...
jetSI-ENDO is an easy-to-use siRNA transfection reagent that has been shown to knock out endogenous genes in a variety of cell lines. jetSI-ENDO is serum compatible and comes with an optimized, strai
Biology Products: